San Francisco-based Signos develops a comprehensive metabolic health platform. It includes a proprietary AI engine with a CGM to provide real-time data and recommendations for weight management. Signos aims for its metabolic-led solution to reverse prediabetes and aid those on their weight loss journey.
Previously only available for non-diabetics, the company expanded its platform to support people with type 2 diabetes earlier this year.
Get the full story at our sister site, Drug Delivery Business News.